Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829374 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
A Phase 3 study, sponsored by Medivation.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,003
- Enrollment target
NCT00829374 is a Phase 3 study that has completed, run by Medivation. The registered enrollment target is 1,003 participants.
The verdict
NCT00829374, a Phase 3 study, has completed, sponsored by Medivation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,003 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
Interventions
- DRUG Placebo comparator
- DRUG Dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,003 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00829374
The ClinicalTrials.gov registry entry for NCT00829374 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,003 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator is the first listed.
NCT00829374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00829374 about?
NCT00829374 is a clinical study titled "Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil". The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
What is the current status of trial NCT00829374?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,003 participants. The study started on 2009-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00829374?
The interventions under investigation include: Placebo comparator (DRUG), Dimebon (DRUG).
Who is sponsoring clinical trial NCT00829374?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.